Answers are grounded in this paper and cite their sources.
Microplastic and nanoplastic exposures reduce osteogenic culture output and alter skeletal responses in experimental models, but they do not produce a uniform loss of bone mass. This critical narrative review searched PubMed and Europe PMC through 30 October 2026 and synthesizes 60 original journal reports spanning human detection, cell function, developmental mineralization, joint pathology, and indirect marrow or exposure evidence. Lower alkaline phosphatase or mineralization output recurs in selected cultures, sometimes alongside reduced survival; impairment per surviving cell remains unresolved. Tissue outcomes differ by compartment and disease background. Developmental co-exposure studies include both a particle-only null result with greater combined-exposure injury and cartilage findings whose direction depends on the single-exposure comparator. Chondrocyte knockdown and pharmacological experiments support selected lysosomal and inflammatory stress pathways, whereas expression-only targets provide less direct mechanistic evidence. Arthritis can persist longer without detectable exposure-related microbiome changes, so dysbiosis is not an established explanation across models. Conditioned-medium and extracellular-vesicle preparations affect recipient cells, but donor signals and transferred particles are incompletely separated. Human detection and cross-sectional associations do not establish skeletal disease causality. Priorities are function per viable cell, specific mechanistic perturbations, verified internal exposure, and functional injury outcomes. The appraised studies provide no direct functional assessment of fracture or bone-defect healing.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: